AMERISAFE (AMSF) Earnings Date & Reports

Key Takeaways

• AMERISAFE is scheduled to report its 2026 third-quarter results on Wednesday, October 28, 2026, after the market closes, followed by a conference call on October 29.
• Consensus estimates point to earnings per share (EPS) of roughly $0.47 to $0.49 on revenue near $84.7 million, compared with $0.55 per share on $71.29 million in the prior-year quarter.
• The company has posted nine consecutive quarters of premium growth, but rising loss costs and medical inflation have pressured underwriting margins.
• Investors will focus on the combined ratio, a key profitability measure, along with reserve development and net investment income.
• Recent quarters have featured earnings misses on the operating (non-GAAP) line despite solid top-line momentum.

Earnings Context and Why It Matters

AMERISAFE, Inc. (Nasdaq: AMSF) is a specialty provider of workers' compensation insurance focused on small to mid-sized employers in high-hazard industries such as construction, trucking, agriculture, and manufacturing. This report matters because it tests whether the company can keep growing premiums while protecting profitability in a softening workers' compensation market. AMERISAFE has expanded premiums for nine straight quarters, but a multi-year decline in industry pricing, combined with higher medical costs, has squeezed underwriting results. The stock has traded well below its 52-week high, making this release an important signal on whether margin pressures are stabilizing or intensifying.

Earnings Expectations

Wall Street analysts expect AMERISAFE to report third-quarter earnings of approximately $0.47 to $0.49 per share, with revenue near $84.7 million. That compares with $0.55 per share on $71.29 million in revenue in the same period a year ago, reflecting both premium growth and expected margin compression. In the second quarter, the company reported operating EPS of $0.44, missing the roughly $0.52 consensus, even as revenue came in above expectations on an 11.4% increase in net premiums earned.

Key metrics investors will scrutinize include gross premiums written, net premiums earned, the net combined ratio (total losses and expenses divided by earned premium), the current accident-year loss ratio, favorable reserve development from prior years, and net investment income. Management has guided toward disciplined, mid-single-digit organic growth while contending with mid-single-digit rate declines in several large states and persistent medical inflation.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help identify trade ideas, trending stocks, breakout candidates, and market opportunities far more efficiently than manual screening. For investors tracking names like AMSF ahead of key catalysts such as quarterly earnings, the AI Screener offers a structured way to surface relevant setups.

Market Reaction and Investor Sentiment

Sentiment heading into the report is cautious. AMERISAFE shares have declined sharply from their 52-week high and recently traded near $25, reflecting investor concern about underwriting margins rather than demand. The company's last several quarters have shown a pattern of strong premium growth offset by higher loss and loss adjustment expenses, which has kept pressure on the bottom line. Analysts carry a broadly neutral "Hold" stance on the stock, suggesting limited conviction ahead of the print. Key risk factors include further deterioration in the accident-year loss ratio, weaker reserve releases, and any indication that pricing competition is accelerating in its core high-hazard niche.

Forward Outlook and Key Factors to Monitor

Following the earnings release, investors should watch whether the company sustains its premium-growth streak and whether the combined ratio begins to stabilize. A combined ratio below 100% indicates underwriting profitability, so the direction of this measure from the 93.2% reported in the first quarter will be closely tracked.

Medical inflation and claims severity remain the central cost concern. Management has noted that industry-wide medical severity has been rising even as claim frequency declines, a dynamic that could keep loss ratios elevated. Rate adequacy will also be important, as several of AMERISAFE's largest states have filed for mid-single-digit rate decreases in 2026.

On the positive side, the company's conservative, high-quality investment portfolio and steady net investment income provide a cushion, and favorable reserve development from older accident years has historically supported results. Capital returns through dividends and share repurchases, as well as book value per share growth, round out the metrics that long-term shareholders will want to monitor.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations